Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tesaro Inc (TSRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,126,323
  • Shares Outstanding, K 55,047
  • Annual Sales, $ 223,330 K
  • Annual Income, $ -496,130 K
  • 60-Month Beta 0.38
  • Price/Sales 18.69
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.86
  • Most Recent Earnings -2.49 on 11/01/18
  • Next Earnings Date 02/26/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -2.45
  • Number of Estimates 9
  • High Estimate -2.28
  • Low Estimate -2.89
  • Prior Year -3.35
  • Growth Rate Est. (year over year) +26.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.59 +3.26%
on 12/21/18
75.16 -0.27%
on 12/28/18
+1.50 (+2.04%)
since 12/18/18
3-Month
23.41 +220.21%
on 11/09/18
75.16 -0.27%
on 12/28/18
+31.98 (+74.41%)
since 10/18/18
52-Week
23.41 +220.21%
on 11/09/18
75.16 -0.27%
on 12/28/18
+11.46 (+18.05%)
since 01/18/18

Most Recent Stories

More News
Actor Scott Foley and TESARO Team Up to Empower Ovarian Cancer Care Partners Through New Phase of Not on My Watch Movement

TESARO, Inc., an oncology-focused business within GSK, announced today that acclaimed actor Scott Foley (TV's Felicity, Scandal and the new ABC series, Whiskey Cavalier) has joined the nationwide Not on...

TSRO : 74.96 (+0.03%)
TESARO, Inc. Provides Notice of Fundamental Change, Conversion Rate Adjustment pursuant to Make-Whole Adjustment Event and Supplemental Indenture

TESARO, Inc. (the "Company" or "TESARO"), an oncology-focused biopharmaceutical company, today announced that pursuant to the terms of the Indenture and the First Supplemental Indenture to the Indenture...

TSRO : 74.96 (+0.03%)
Implied Volatility Surging for Tesaro (TSRO) Stock Options

Investors need to pay close attention to Tesaro (TSRO) stock based on the movements in the options market lately.

TSRO : 74.96 (+0.03%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. ("Tesaro" or "the Company") (NASDAQ: TSRO) for violations of §§10(b)...

TSRO : 74.96 (+0.03%)
CLASS ACTION UPDATE for TSRO and PPDF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

PPDF : 5.19 (-5.64%)
TSRO : 74.96 (+0.03%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TSRO and MGI

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

TSRO : 74.96 (+0.03%)
MGI : 2.75 (-4.51%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline - TSRO

Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers. The class action, filed in United States...

TSRO : 74.96 (+0.03%)
SINGLE TICKER NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Tesaro, Inc. - TSRO

NEW YORK / ACCESSWIRE / January 3, 2019 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Tesaro, Inc. (NASDAQ: TSRO) from November...

TSRO : 74.96 (+0.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline - TSRO

NEW YORK, NY / ACCESSWIRE / January 3, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (''Tesaro'' or the ''Company'') (NASDAQ: TSRO) and certain of its officers....

TSRO : 74.96 (+0.03%)
SHAREHOLDER ALERT: ALGN RYAAY RBBN (formerly SONS) TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

RBBN : 5.15 (-3.56%)
TSRO : 74.96 (+0.03%)
ALGN : 299.85 (+0.93%)
RYAAY : 77.33 (-1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade TSRO with:

Business Summary

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor...

See More

Key Turning Points

2nd Resistance Point 74.99
1st Resistance Point 74.97
Last Price 74.96
1st Support Level 74.94
2nd Support Level 74.93

See More

52-Week High 75.16
Last Price 74.96
Fibonacci 61.8% 55.39
Fibonacci 50% 49.29
Fibonacci 38.2% 43.18
52-Week Low 23.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar